Immediate Impact
23 standout
Citing Papers
Smart hydrogel: A new platform for cancer therapy
2025 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Xuebin Han being referenced
Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)
2023
Research progress of biomarkers in early detection of chemotherapy-induced cardiotoxicity
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xuebin Han | 74 | 57 | 79 | 17 | 208 | |
| Mordechai Golomb | 83 | 82 | 42 | 22 | 236 | |
| Stefan Beer | 77 | 75 | 78 | 16 | 278 | |
| Hui Liu | 61 | 62 | 42 | 26 | 260 | |
| Leonardo Pinto de Carvalho | 134 | 57 | 116 | 23 | 296 | |
| So‐Young Lee | 33 | 53 | 81 | 27 | 253 | |
| Akhil Pampana | 61 | 40 | 56 | 17 | 182 | |
| H. Marx | 47 | 139 | 56 | 20 | 249 | |
| Ahmad Al‐Sarraf | 119 | 159 | 58 | 19 | 274 | |
| Stella McGinn | 47 | 28 | 105 | 13 | 233 | |
| Shouyuan Ma | 78 | 33 | 62 | 16 | 239 |
All Works
Loading papers...